DNAPrint Genomics Inc.'s Ellipsis Biotherapeutics Corporation Subsidiary To Exhibit At The American Society of Human Genetics Meeting

TORONTO and SARASOTA, FL -- (MARKET WIRE) -- October 09, 2006 -- DNAPrint Genomics, Inc. (OTCBB: DNAG) today announced that representatives of Ellipsis Biotherapeutics Corporation, a wholly owned subsidiary of DNAPrint Genomics, will exhibit at the American Society of Human Genetics Meeting, the premier annual international human genetics meeting, to be held at the Ernest N. Morial Convention Center, starting today and continuing through October 13 in New Orleans.

MORE ON THIS TOPIC